Efficacy of thalidomide in the treatment of refractory ankylosing spondylitis

Arthritis Rheum. 1999 Mar;42(3):580-1. doi: 10.1002/1529-0131(199904)42:3<580::AID-ANR27>3.0.CO;2-D.
No abstract available

Publication types

  • Clinical Trial

MeSH terms

  • Adult
  • Blood Sedimentation
  • C-Reactive Protein / analysis
  • Humans
  • Immunosuppressive Agents / administration & dosage*
  • Male
  • Spondylitis, Ankylosing / drug therapy*
  • Thalidomide / administration & dosage*

Substances

  • Immunosuppressive Agents
  • Thalidomide
  • C-Reactive Protein